According to The Fly, research analysts at Mizuho raised their price target for Xylem (NYSE: XYL) in a Friday research note emailed to clients and investors. The new price target is $105.00, up from the previous price target of $88.00. The price objective that Mizuho has established demonstrates a decrease of 9.63% when compared to the current price of the company when viewed in comparison to the current price.
Recent months have seen increased interest in XYL from various brokerage firms. Stifel Nicolaus increased their target price for the company from $113.00 to $115.00 and downgraded Xylem from a “buy” rating to a “hold” rating in a research report published on Monday, December 19. Stifel Nicolaus also downgraded Xylem from a “buy” rating to a “hold” rating. TheStreet lowered its rating of Xylem from “b-” to “c” in a research note published on November 1. This change was made to reflect the company’s worsening performance. In a research note published on November 16, Atlantic Securities raised their price target for Xylem from $110.00 to $129.00 and shifted their recommendation for the stock from “neutral” to “overweight.” According to a research report distributed by Cowen on November 2, the investment firm increased its price target for Xylem shares from $105.00 to $115.00. On October 12, StockNews.com published a piece that marked the beginning of their coverage of Xylem shares. They recommended that shareholders “hold” their shares of the company. One of the equity research analysts has given the stock a sell rating; seven have recommended holding the stock, and five have given the stock a buy rating. According to Bloomberg, the current average rating for the stock is “Hold,” and analysts have established the price target for the stock is $112.60. The price target was determined by consensus.
When trading started on Friday, one share of XYL was valued at $116.19 per dollar. Over the previous twelve months, the price of Xylem ranged from a low of $72.08 to a high of $117.00. The company’s moving average over the past 200 days is $98.15, and the moving average for the last 50 days is $111.17. The company’s market capitalization is currently sitting at $20.94 billion, while its P/E ratio is 66.02, its PEG ratio is 2.91, and its beta coefficient is 1.09. The current, quick, and debt-to-equity ratios all come in at 1.65, while the debt-to-equity ratio sits at 0.58. The current ratio, the quick ratio, and the debt-to-equity ratio all come in at 1.65.
Xylem (NYSE: XYL) disseminated the findings of its most recent quarterly financial report on November 1, which was a Tuesday. Earnings for the quarter came in at $0.79 per share for the industrial goods company, which was $0.13 higher than the consensus estimate of $0.66 per share among industry analysts. The revenue for the quarter came in at $1.38 billion, which is considerably higher than the average prediction of $1.33 billion made by the market. The net margin for Xylem came in at 5.97%, and the company’s return on equity was 14.40%; both figures are relatively high. According to projections made by sell-side analysts, Xylem will bring in an average of $2.71 in profits per share during the current financial year.
On Friday, November 4, Senior Vice President Matthew Francis Pine sold 11,870 Xylem stock shares, as reported in other news regarding the company. This transaction was recorded in a journal. The shares were finally sold for $1,271,514.40 after being purchased at an average price of $107.12 per share by purchasers. This brought in a total of $1,271,514.00. At this time, the senior vice president personally owns 22,819 shares of the company. Based on current market conditions, these shares’ value is estimated to be close to $2,444,371.28. If you follow the link, which will take you to a legal file submitted to the SEC, you will have the opportunity to acquire additional information regarding the transaction. The company’s insiders own 0.89 percent of the total number of shares outstanding.
Recently, several hedge funds made adjustments to the holdings that they had in XYL. Householder Group Estate & Retirement Specialist LLC invested approximately $27,000 to acquire a new interest in Xylem during the third quarter of the fiscal year. During the second quarter, Clear Street Markets LLC increased the proportion of Xylem stock owned by 408.1 percent. Clear Street Markets LLC now has a total of 376 shares of the industrial products company’s stock, each of which has a value of $29,000, thanks to the purchase of an additional 302 shares during the period that immediately preceded the one in which we are currently located. ACG Wealth increased its holdings of Xylem during the second quarter by investing approximately $31,000. Heritage Financial Services LLC invested approximately $31,000 during the second quarter to increase its ownership in Xylem and acquire a larger stake in the company. And finally, but certainly not least, during the third quarter, TCI Wealth Advisors Inc. increased the amount of Xylem stock held by 583.3 percent, bringing the total amount of stock it held to a total value of $1. After purchasing an additional 315 shares throughout the relevant period, TCI Wealth Advisors Inc. now has a total of 369 shares of the industrial products company’s stock, each of which has a value of $32,000. During the relevant period, these shares were acquired. Institutional investors, including hedge funds and various other types, currently own 83.57% of the company’s shares.
Xylem Inc. and its subsidiaries develop, manufacture, and offer after-sales service for designed products and solutions for water and wastewater applications worldwide, including in the United States of America, Europe, Asia Pacific, and every other region. These applications can be found anywhere water and wastewater are used. The company is broken up into three distinct business divisions: Measurement & Control Solutions, Applied Water, and Water Infrastructure.